Success Stories: Overcoming the Odds: NIW Approval Secured After RFE with NAILG’s Strategic Guidance

Client’s Testimonial:

“Thank you so much for letting me know. I am glad that it has been approved, barring the RFE. It has been an absolute pleasure working with the firm as well! Thank you for making me feel confident throughout the entire process!”

On February 3^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Machine Learning Engineer in the Field of Artificial Intelligence (Approval Notice).

General Field: Artificial Intelligence

Position at the Time of Case Filing: Senior Machine Learning Engineer

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: February 3^rd, 2025

Processing Time: 2 months, 30 days (Premium Processing Requested)

Case Summary:

We are pleased to share the NIW (National Interest Waiver) approval of a highly accomplished artificial intelligence researcher whose work is driving innovation in digital health. Filed in November 2024, this petition received a Request for Evidence (RFE) just 10 days later, which was successfully overcome with a strategic response from the North America Immigration Law Group (NAILG). The petition was approved on February 3, 2025, only 2 months and 30 days after submission.

Well Positioned to Advance the Proposed Endeavor:
The petitioner is engaged in cutting-edge research aimed at building AI systems that model and predict human health and behavior. His work supports the development of real-time digital interventions, improved clinical decision-making tools, and wearable health-monitoring technologies. These systems enhance the quality of care for vulnerable populations and improve outcomes in cancer recovery, substance use treatment, and chronic disease management.

Backed by prestigious U.S. funding institutions such as the Office of the Director of National Intelligence (ODNI), IARPA, the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Department of Health and Human Services (HHS), his contributions address national priorities in healthcare and data science.

Demonstrated Record of Success:
To date, the petitioner has published 6 peer-reviewed journal articles, 1 peer-reviewed conference paper, and 5 abstracts. His research has been cited 349 times, demonstrating widespread academic influence. These contributions have strengthened digital health systems that use machine learning to track patient symptoms and deliver personalized care.

Peer Recognition:
His expertise is further validated by a compelling testimonial submitted with the petition, which states:

“Without a doubt, it is clear that [client] stands at the top of his field, given his success in creating real-time mobile interventions for cancer recovery, integrating artificial intelligence-driven monitoring systems, and improving symptom tracking through wearable technology.”

NAILG’s Role in Overcoming the RFE:
Despite receiving an early RFE, NAILG prepared a comprehensive and tailored response that addressed the USCIS’s concerns head-on. Our legal team highlighted the societal impact, originality, and future potential of his work. The resulting approval reflects both the strength of the case and NAILG’s dedication to helping exceptional researchers secure immigration benefits under the NIW program.

We are proud to have represented this client and look forward to the continued impact of his work in advancing digital health innovation through artificial intelligence.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.